Impact of Hypertension History and Blood Pressure at Presentation on Cardiac Remodeling and Mortality in Aortic

Matheus F R A Oliveira1, Walter E M Rocha1, Julia D Soares2

  • 1Department of Internal Medicine, School of Medical Sciences, State University of Campinas, São Paulo, Brazil.

Insights

Blood pressure at presentation impacts aortic dissection outcomes differently based on hypertension history. Understanding these factors aids in predicting mortality and organ damage in aortic dissection patients.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Aortic Dissection Studies

Background:

  • Aortic dissection (AD) poses significant mortality risks.
  • The role of baseline blood pressure (BP) and hypertension history in AD prognosis requires further clarification.
  • Left ventricular (LV) remodeling and renal dysfunction are critical complications of AD.

Purpose of the Study:

  • To compare clinical, echocardiographic, and prognostic features of AD patients with and without a history of hypertension (HypHist vs. No-HypHist).
  • To evaluate the association of presenting BP with 1-year mortality, LV remodeling, and renal dysfunction in AD.
  • To investigate the influence of hypertension history and antihypertensive medication use on BP-mortality relationships in AD.

Main Methods:

  • A cohort of 367 AD patients (81% HypHist, 66% Type-A) from three Brazilian centers was analyzed.
  • Clinical and echocardiographic characteristics were collected and compared between HypHist and No-HypHist groups.
  • Statistical analyses included multivariable logistic regression and restricted cubic spline analysis to assess BP associations with outcomes.

Main Results:

  • No-HypHist patients were more likely to have Marfan syndrome or bicuspid aortic valve and less LV hypertrophy.
  • A J-curve association between presenting systolic and diastolic BP and mortality was observed in No-HypHist patients, but not in HypHist patients.
  • Presenting BP was directly associated with LV hypertrophy and concentricity, and pulse pressure inversely associated with reduced eGFR in the overall AD cohort.

Conclusions:

  • Presenting BP, hypertension history, and antihypertensive medication use are crucial for predicting mortality risk in AD.
  • These factors may also help estimate the extent of extra-aortic end-organ damage in AD patients.
  • Tailored risk stratification for AD should consider the interplay between baseline BP, hypertension status, and treatment history.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
63
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
71
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
61
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
76
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
43
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
91